David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 3,808 shares at $35.01 ($133K) on 2013-05-29, disclosed to the SEC on 2013-05-31.
Scheduled sale ($133k) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |
| THRX | SELL | 2012-08-07 | $3.5M | — | Filing → |